TipRanksTop Financial ExpertsInsidersAndrew John.William Heath

Andrew John.William Heath Insider Profile

4 Followers
Andrew John.William Heath, Director at Shield Therapeutics, holds 89.05K shares in Shield Therapeutics (Ticker: GB:STX). Most recently, Andrew John.William Heath Bought 3,334p shares of Shield Therapeutics on Jun 15, 2017 for an estimated value of 5.00K.
tipranks
Andrew John.William Heath

Andrew John.William Heath
Shield Therapeutics (STX)
Director

Not Ranked
Andrew John.William Heath has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

£2K
100.00%
A breakdown of Andrew John.William Heath's holdings

Insider Roles

Shield Therapeutics
(STX)
Director
Roles that Andrew John.William Heath holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Andrew John.William Heath

Andrew John.William Heath's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Shield Therapeutics
Jun 15, 2017
Director
Informative Buy
5.00K
£2.45K
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jun 15, 2017
Informative Buy
£5.00K
-
£150.00
List of latest transactions for each holding click on a transaction to see Andrew John.William Heath's performance on stock

Andrew John.William Heath insider profile FAQ

What is the percentage of profitable transactions made by Andrew John.William Heath?
The percentage of profitable transactions made by Andrew John.William Heath is ―.
    What is the average return per transaction made by Andrew John.William Heath?
    The average return per transaction made by Andrew John.William Heath is ―.
      What stocks does Andrew John.William Heath hold?
      Andrew John.William Heath holds: GB:STX stocks.
        What was Andrew John.William Heath’s latest transaction?
        Andrew John.William Heath latest transaction was an Informative Buy of 5.00K.
          What was Andrew John.William Heath's most profitable transaction?
          Andrew John.William Heath’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Andrew John.William Heath's role in Shield Therapeutics?
            Andrew John.William Heath's role in Shield Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.